IMUC
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jul 24 closing price
Capitalization
12.65M
SRPT
Price
$11.93
Change
-$0.95 (-7.38%)
Updated
Jul 25 closing price
Capitalization
1.17B
3 days until earnings call
Interact to see
Advertisement

IMUC vs SRPT

Header iconIMUC vs SRPT Comparison
Open Charts IMUC vs SRPTBanner chart's image
EOM Pharmaceutical Holdings
Price$0.10
Change-$0.00 (-0.00%)
Volume$2.15K
Capitalization12.65M
Sarepta Therapeutics
Price$11.93
Change-$0.95 (-7.38%)
Volume$15.89M
Capitalization1.17B
IMUC vs SRPT Comparison Chart in %
Loading...
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUC vs. SRPT commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUC is a StrongBuy and SRPT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (IMUC: $0.10 vs. SRPT: $11.93)
Brand notoriety: IMUC: Not notable vs. SRPT: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUC: 103% vs. SRPT: 174%
Market capitalization -- IMUC: $12.65M vs. SRPT: $1.17B
IMUC [@Biotechnology] is valued at $12.65M. SRPT’s [@Biotechnology] market capitalization is $1.17B. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUC’s FA Score shows that 1 FA rating(s) are green whileSRPT’s FA Score has 0 green FA rating(s).

  • IMUC’s FA Score: 1 green, 4 red.
  • SRPT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMUC is a better buy in the long-term than SRPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUC’s TA Score shows that 4 TA indicator(s) are bullish while SRPT’s TA Score has 5 bullish TA indicator(s).

  • IMUC’s TA Score: 4 bullish, 3 bearish.
  • SRPT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SRPT is a better buy in the short-term than IMUC.

Price Growth

IMUC (@Biotechnology) experienced а +25.00% price change this week, while SRPT (@Biotechnology) price change was -15.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

IMUC is expected to report earnings on Nov 20, 2024.

SRPT is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRPT($1.17B) has a higher market cap than IMUC($12.7M). SRPT has higher P/E ratio than IMUC: SRPT (27.21) vs IMUC (0.02). IMUC YTD gains are higher at: -40.758 vs. SRPT (-90.188). IMUC has higher annual earnings (EBITDA): -5.65M vs. SRPT (-106.51M). SRPT has more cash in the bank: 523M vs. IMUC (85.3K). SRPT has higher revenues than IMUC: SRPT (2.23B) vs IMUC (0).
IMUCSRPTIMUC / SRPT
Capitalization12.7M1.17B1%
EBITDA-5.65M-106.51M5%
Gain YTD-40.758-90.18845%
P/E Ratio0.0227.210%
Revenue02.23B-
Total Cash85.3K523M0%
Total DebtN/A1.34B-
FUNDAMENTALS RATINGS
IMUC vs SRPT: Fundamental Ratings
IMUC
SRPT
OUTLOOK RATING
1..100
303
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
59
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
8898
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMUC's Valuation (9) in the Biotechnology industry is somewhat better than the same rating for SRPT (59). This means that IMUC’s stock grew somewhat faster than SRPT’s over the last 12 months.

IMUC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that IMUC’s stock grew similarly to SRPT’s over the last 12 months.

SRPT's SMR Rating (94) in the Biotechnology industry is in the same range as IMUC (100). This means that SRPT’s stock grew similarly to IMUC’s over the last 12 months.

IMUC's Price Growth Rating (88) in the Biotechnology industry is in the same range as SRPT (98). This means that IMUC’s stock grew similarly to SRPT’s over the last 12 months.

IMUC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SRPT (100). This means that IMUC’s stock grew similarly to SRPT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMUCSRPT
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
60%
Bullish Trend 10 days ago
74%
Declines
ODDS (%)
Bearish Trend 25 days ago
90%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
IMUC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSMGX20.480.12
+0.59%
Wilshire Small Company Growth Instl
GGGCX51.870.26
+0.50%
Gabelli Global Growth C
FMAMX85.190.31
+0.37%
Fidelity Advisor Stock Sel A
DRDIX26.450.07
+0.27%
Dearborn Partners Rising Dividend I
SLADX38.230.06
+0.16%
Selected American Shares D

IMUC and

Correlation & Price change

A.I.dvisor tells us that IMUC and GRCE have been poorly correlated (+7% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMUC and GRCE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUC
1D Price
Change %
IMUC100%
N/A
GRCE - IMUC
7%
Poorly correlated
-3.75%
TNXP - IMUC
6%
Poorly correlated
+9.24%
SRPT - IMUC
5%
Poorly correlated
-7.38%
ORMP - IMUC
5%
Poorly correlated
N/A
PTCT - IMUC
4%
Poorly correlated
-3.41%
More

SRPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRPT has been loosely correlated with ALZN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SRPT jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRPT
1D Price
Change %
SRPT100%
-7.38%
ALZN - SRPT
49%
Loosely correlated
-1.00%
AXON - SRPT
43%
Loosely correlated
+3.63%
SYRE - SRPT
41%
Loosely correlated
+1.08%
SLDB - SRPT
40%
Loosely correlated
+4.79%
ARVN - SRPT
39%
Loosely correlated
-0.63%
More